Brain Cancer - Collaborating for a Cure
from Bench to Bedside Hosted by The University of Kansas Cancer Center
The prognosis for brain cancer has not changed much over the last few decades, but researchers at The University of Kansas Cancer Center are working to change that. Dr. David Akhavan, radiation oncologist and physician-scientist, will share how immunotherapy for brain cancer is the next breakthrough in research. Also joining the conversation will be Matt Anthony, founder of Head for the Cure and a cancer survivor.
Embed this episode
No transcript yet.
Frequently asked questions
How long is this episode of Bench to Bedside?
This episode is 38 minutes long.
When was this Bench to Bedside episode published?
This episode was published on October 27, 2021.
Can I download this Bench to Bedside episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.